CRESILON, INC.
Cresilon is a medical device company that produces and markets solutions for trauma care. The company’s proprietary product, VETIGEL(TM), is a hemostatic gel made from plant-derived materials to stop traumatic bleeding in seconds. It functions as a blood-clotting agent, and also as a scaffold to facilitate skin growth. Cresilon was co-founded by Joe Landolina and Isaac Miller in 2010 and is based in New York, United States.
CRESILON, INC.
Industry:
Biotechnology Health Care Medical Medical Device
Founded:
2010-09-01
Address:
Brooklyn, New York, United States
Country:
United States
Website Url:
http://www.cresilon.com
Total Employee:
11+
Status:
Active
Contact:
+1 (347) 435-2226
Email Addresses:
[email protected]
Total Funding:
51.8 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Interventional Imaging
Interventional Imaging, Inc. operates as a medical device company that focuses on magnetic resonance (MR)-based imaging and interventions.
ITeos Therapeutics
ITeos Therapeutics is a biotechnology company that specializes in tumor immunology, cancer immunotherapy, and drug discovery.
PanTheryx
PanTheryx is a nutrition and biotechnology company that utilizes the cellular and biomolecular processes of bovine colostrum.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Current Advisors List
Current Employees Featured
Founder
Investors List
Innovating Capital
Innovating Capital investment in Series A - Cresilon, Inc.
Dorm Room Fund
Dorm Room Fund investment in Seed Round - Cresilon, Inc.
Official Site Inspections
http://www.cresilon.com Semrush global rank: 4.18 M Semrush visits lastest month: 2.83 K
- Host name: 192.0.78.187
- IP address: 192.0.78.187
- Location: San Francisco United States
- Latitude: 37.7506
- Longitude: -122.4121
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94110
More informations about "Cresilon, Inc."
Management - Cresilon
MANAGEMENT MANAGEMENT The right mix of passion and experience. Joe Landolina CEO, Co-founder Isaac Miller EVP, Co-founder Scott Levine Chief …See details»
Cresilon - LinkedIn
Any federal organization can purchase directly using DAPA contract number: SP0200-10-H-0092. ... New York, Cresilon, Inc. is a privately-held medical …See details»
Cresilon - The Org
Cresilon 0 followers Headquartered in Brooklyn, New York, Cresilon, Inc. is a privately-held medical device company focused on hemostatic technologies that improve wound care and …See details»
Cresilon Management Team | Org Chart - RocketReach
Cresilon Management Headquartered in Brooklyn, New York, Cresilon, Inc. is a privately-held medical device company focused on hemostatic technologies that improve wound care and …See details»
Org Chart Cresilon - The Official Board
Cresilon has 13 executives. Cresilon; Please confirm your deletion . Delete or Cancel . Unfortunately, you don't own enough credit to see this new org chart. To continue, you can …See details»
Cresilon - Crunchbase Company Profile & Funding
Cresilon is a medical device company that produces and markets solutions for trauma care. The company’s proprietary product, VETIGEL, is a hemostatic gel made from plant-derived …See details»
Cresilon Company Profile | Management and Employees List
Cresilon Profile and History. Cresilon is a biotechnology company that develops, manufactures, and markets hemostatic medical devices utilizing the company's proprietary hydrogel …See details»
Cresilon - NYU Tandon School of Engineering
Landolina and Cresilon — which was included on the 2024 list of Fast Company’s most innovative companies, landing in the top spot in the medical device category — have come a long way …See details»
Cresilon | Catalio Capital Portfolio
Cresilon is a commercial stage medical device company that manufactures and sells an algae-derived polymer gel used to stop bleeding. Cresilon currently has products for both veterinary …See details»
Home - Cresilon
Cresilon’s current and future product lines target veterinary, human trauma, and human surgical applications. Our Story. Constantly experimenting with natural materials in the lab as a young …See details»
Cresilon - 2025 Company Profile, Funding & Competitors - Tracxn
Apr 25, 2025 Cresilon is a series B company based in New York City (United States), founded in 2010 by Joe Landolina. It operates as a Developer of hemostatic products for wound care. …See details»
Cresilon's Leadership Team - Team members and org chart - The …
The leadership team at Cresilon has a wealth of experience in the pharmaceutical and healthcare industries, as well as in management and consulting. They have worked for companies such …See details»
Cresilon - mtec-sc.org
Cresilon is a Brooklyn-based biotech company dedicated to saving lives through innovative hemostatic solutions. Their mission is to provide safe, effective, and reliable products that stop …See details»
Cresilon Receives First FDA Clearance For Human Use of
Jun 29, 2023 Cresilon® is a Brooklyn-based biotechnology company that develops, manufactures, and markets hemostatic medical devices utilizing the company's proprietary …See details»
Our Story - Cresilon
OUR STORY Constantly experimenting with natural materials in the lab as a young adult, Joe Landolina developed an adhesive hemostatic gel composed of plant-based polymers that …See details»
Embracing a new name: Cresilon - LinkedIn
Sep 1, 2016 Coming from the Latin root for growth ("cres") and the Hebrew root for oak tree ("alon"), Cresilon is meant to invoke an organization that has its roots in nature, drawing …See details»
Cresilon Information - RocketReach
Headquartered in Brooklyn, New York, Cresilon, Inc. is a privately-held medical device company focused on hemostatic technologies that improve wound care and advance the standard of …See details»
Cresilon Closes $25 Million in Series A-4 Financing to Accelerate ...
NEW YORK, Oct. 27, 2022 — Cresilon, Inc., the Brooklyn-based biotechnology company developing and manufacturing innovative hemostatic medical device technologies, today …See details»
Cresilon Receives FDA Clearance for TRAUMAGEL - Newswire
Aug 15, 2024 Cresilon ® is a Brooklyn-based biotechnology company that develops, manufactures, and markets hemostatic medical devices utilizing the company's proprietary …See details»
Cresilon Closes $38.5 Million Series A-3 Financing to Accelerate ...
Sep 30, 2021 NEW YORK, April 8, 2021 – Cresilon, Inc., the Brooklyn-based biotechnology company, announced today the successful close of its Series A-3 financing, totaling $38.5 …See details»